RecruitingNot ApplicableNCT05026723

Food as Medicine for HIV and Diabetes

Food as Medicine for HIV: A Randomized Trial of Medically Tailored Meals and Lifestyle Intervention


Sponsor

University of North Carolina, Chapel Hill

Enrollment

200 participants

Start Date

Oct 4, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

This is a single-site, open-label, Phase II, community-based randomized controlled explanatory trial to test the efficacy of a medically tailored meal + intensive lifestyle intervention (MTM + ILI) intervention for adults with food insecurity, HIV, and T2DM or high risk of T2DM, compared with a group that receives usual MTM.


Eligibility

Min Age: 18 Years

Inclusion Criteria10

  • Male or female
  • Diagnosis of HIV
  • Diagnosis of Type 2 Diabetes Mellitus or high risk for type 2 diabetes mellitus, defined as meeting CDC eligibility criteria for the diabetes prevention program. Specifically, an individual without a diagnosis of T2DM must 1) have had a blood test result in the prediabetes range within the past year (Hemoglobin A1C: 5.7-6.4% OR Fasting plasma glucose: 100-125 mg/dL OR Two-hour plasma glucose \[after a 75 g glucose load\]: 140-199 mg/dL), 2) Have been previously diagnosed with gestational diabetes, OR 3) have a high-risk result (score of 5 or higher) on the Prediabetes Risk Test (https://www.cdc.gov/prediabetes/pdf/Prediabetes-Risk-Test-Final.pdf)
  • Experiencing food insecurity as indicated by 2-item Hunger Vital Sign
  • English speaking
  • Aged ≥18 years
  • BMI ≥ 23 kg/m2
  • No plans to move from the area for at least 1 year
  • Free living to the extent that participant has control over dietary intake
  • Willing and able to provide written informed consent and participate in all study activities

Exclusion Criteria12

  • Participant in diabetes, nutrition, or weight research intervention in last 12 months
  • Current AIDS defining illness
  • Another family member or household member is a study participant. Only one member of each household may take part in this study.
  • Considering bariatric surgery in the next year or prior bariatric surgery in the past 2 years
  • Lack of safe, stable residence and ability to store meals
  • Lack of telephone
  • Pregnancy/breastfeeding or intended pregnancy in the next year
  • History of malignancy, other than non-melanoma skin cancer, unless surgically or medically cured \> 5 years ago or in remission. Patients with localized prostate and breast cancer diagnosed during the course of routine screening will not be excluded.
  • Advanced kidney disease (estimated creatinine clearance \< 30 ml/min)
  • Known drug or alcohol misuse in the past 6 months
  • Known psychosis or major psychiatric illness that prevents participation with study activities
  • Intermittent use of medications (e.g., oral or intravenous glucocorticoids) that are likely to affect blood sugar

Interventions

BEHAVIORALMTM + ILI

Weekly home meal delivery; an explanation of the medical tailoring of the meals; and a 20-session telephone lifestyle intervention change program

BEHAVIORALStandard MTM

Weekly home meal delivery; an explanation of the medical tailoring of the meals; and an initial consultation with a dietitian


Locations(1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05026723


Related Trials